Immunitor Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Accesswire. The AP news staff was not involved in its creation. Key Capital Strengthens Vaccine Patents February 18, 2021 GMT Full Patent for Immunitor issued in China and EU Claims being re-filedNEW YORK, NY / ACCESSWIRE / February 18, 2021 / KEY CAPITAL CORPORATION (OTC PINK:KCPC) advises that it continues to work with Immunitor, its partner and Licensor, to progress ... Full Patent for Immunitor issued in China and EU Claims being re-filedNEW YORK, NY / ACCESSWIRE / February 18, 2021 / KEY CAPITAL CORPORATION (OTC PINK:KCPC) advises that it continues to work with...

Key Capital Corporation: Key Capital Strengthens Vaccine Patents Full Patent for Immunitor issued in China and EU Claims being re-filed NEW YORK, NY / ACCESSWIRE / February 18, 2021 / KEY CAPITAL CORPORATION (OTC PINK:KCPC) advises that it continues to work with Immunitor, its partner and Licensor, to progress further research and development of its breakthrough therapeutic vaccines, and for several unique supplements. PATENTS - Expanding Global Protection Key Capital, through its partnering and funding commitment with Immunitor recently finalized full patent filing in China, where local juri...